CMS completes HK$9.69 million on-market buyback, treasury stock rises to 3.08 million shares

Bulletin Express06-03

China Medical System Holdings Limited (CMS) reported to the Hong Kong Stock Exchange that it repurchased 0.90 million ordinary shares on 3 June 2026, deploying HK$9.69 million of cash at prices ranging from HK$10.62 to HK$11.00 per share, with a volume-weighted average cost of HK$10.76.

Following the transaction, the company’s issued share base (excluding treasury shares) decreased by 0.04 % to 2.44 billion shares, while treasury holdings increased from 2.18 million to 3.08 million shares. Total issued shares remain unchanged at 2.44 billion.

The buyback forms part of the mandate authorised on 23 April 2026, which permits the repurchase of up to 243.95 million shares. Cumulative repurchases under this mandate now stand at 3.08 million shares, equivalent to 0.13 % of the company’s issued share capital on the mandate date.

In line with Hong Kong listing rules, CMS is subject to a moratorium on new share issues or treasury share disposals until 3 July 2026. The company confirmed that the repurchase complied with all relevant regulations and internal approvals.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment